Schroder Investment Management Group Buys 85,340 Shares of Ventas, Inc. $VTR

Schroder Investment Management Group grew its position in Ventas, Inc. (NYSE:VTR) by 3.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,487,572 shares of the real estate investment trust’s stock after purchasing an additional 85,340 shares during the quarter. Schroder Investment Management Group owned approximately 0.53% of Ventas worth $170,946,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of VTR. BI Asset Management Fondsmaeglerselskab A S lifted its position in Ventas by 97.7% during the 3rd quarter. BI Asset Management Fondsmaeglerselskab A S now owns 36,713 shares of the real estate investment trust’s stock worth $2,570,000 after acquiring an additional 18,146 shares during the last quarter. Investment Management Corp of Ontario increased its stake in shares of Ventas by 1,019.0% in the second quarter. Investment Management Corp of Ontario now owns 133,061 shares of the real estate investment trust’s stock worth $8,403,000 after purchasing an additional 121,170 shares during the period. Hudson Bay Capital Management LP acquired a new position in shares of Ventas during the 2nd quarter worth about $17,568,000. SCS Capital Management LLC bought a new stake in Ventas during the 2nd quarter valued at approximately $13,788,000. Finally, Y Intercept Hong Kong Ltd grew its holdings in Ventas by 28.5% in the 3rd quarter. Y Intercept Hong Kong Ltd now owns 83,524 shares of the real estate investment trust’s stock valued at $5,846,000 after buying an additional 18,527 shares during the last quarter. 94.18% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on VTR. The Goldman Sachs Group reiterated a “buy” rating and set a $100.00 price target on shares of Ventas in a report on Monday, February 9th. Royal Bank Of Canada lifted their price objective on Ventas from $83.00 to $91.00 and gave the stock an “outperform” rating in a report on Tuesday, February 10th. Jefferies Financial Group reiterated a “buy” rating and set a $93.00 price target on shares of Ventas in a research note on Monday, December 15th. Mizuho boosted their price target on shares of Ventas from $87.00 to $94.00 and gave the company an “outperform” rating in a report on Wednesday, March 4th. Finally, Weiss Ratings upgraded shares of Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $89.00.

Insider Transactions at Ventas

In related news, CFO Robert F. Probst sold 29,930 shares of the stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $77.25, for a total transaction of $2,312,092.50. Following the sale, the chief financial officer directly owned 138,434 shares in the company, valued at $10,694,026.50. This represents a 17.78% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Carey S. Roberts sold 35,532 shares of the business’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total value of $3,020,220.00. Following the completion of the transaction, the executive vice president directly owned 72,755 shares in the company, valued at approximately $6,184,175. This represents a 32.81% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 86,106 shares of company stock valued at $6,931,397 in the last three months. 1.00% of the stock is owned by corporate insiders.

Ventas Stock Performance

Shares of NYSE:VTR opened at $86.22 on Tuesday. The company has a debt-to-equity ratio of 1.03, a current ratio of 0.67 and a quick ratio of 0.67. The business’s fifty day moving average price is $80.79 and its two-hundred day moving average price is $75.93. Ventas, Inc. has a fifty-two week low of $60.15 and a fifty-two week high of $87.87. The stock has a market capitalization of $40.95 billion, a price-to-earnings ratio of 159.66, a price-to-earnings-growth ratio of 2.07 and a beta of 0.73.

Ventas (NYSE:VTR) last issued its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). Ventas had a net margin of 4.31% and a return on equity of 2.09%. The company had revenue of ($1,229.71) million for the quarter, compared to the consensus estimate of $1.53 billion. During the same period in the previous year, the business posted $0.81 earnings per share. The firm’s revenue was up 21.7% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. As a group, analysts predict that Ventas, Inc. will post 3.4 EPS for the current fiscal year.

Ventas Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. This is an increase from Ventas’s previous quarterly dividend of $0.48. The ex-dividend date is Tuesday, March 31st. Ventas’s dividend payout ratio is presently 355.56%.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.